144 related articles for article (PubMed ID: 1832761)
21. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the antihypertensive efficacy of and tolerance to 2 imidazoline receptor agonists: moxonidine and rilmenidine in monotherapy].
Camilleri G; Portal B; Quiniou G; Clerson P
Ann Cardiol Angeiol (Paris); 2001 Apr; 50(3):169-74. PubMed ID: 12555509
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
[TBL] [Abstract][Full Text] [Related]
24. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Scemama M; Février B; Beucler I; Dairou F
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
26. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
[TBL] [Abstract][Full Text] [Related]
28. [Perindopril: first-line treatment of arterial hypertension].
Zanchetti A; Desche P
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
[TBL] [Abstract][Full Text] [Related]
29. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
30. Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.
Kawecka-Jaszcz K; Czarnecka D; Klocek M; Zabojszcz M; Kucharska M; Jaworski R; Pachocki R
Blood Press; 2006; 15(1):51-8. PubMed ID: 16492616
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Chrysant SG; Chavanu KJ; Xu J
Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
[TBL] [Abstract][Full Text] [Related]
33. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of essential hypertension with felodipine or atenolol as first line therapy. Comparative double-blind randomized study].
Lesbre JP; Witchitz S; Andrejak M; Morand P; Raveau-Landon C
Presse Med; 1989 Jan; 18(3):103-6. PubMed ID: 2521934
[TBL] [Abstract][Full Text] [Related]
35. Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study.
Otterstad JE; Froeland G; Soeyland AK; Illingworth JM
Scand J Clin Lab Invest; 1992 Apr; 52(2):83-93. PubMed ID: 1589701
[TBL] [Abstract][Full Text] [Related]
36. Dose-effect relationship of rilmenidine after chronic administration.
Luccioni R; Lambert M; Ambrosi P; Scemama M
Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
38. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
[TBL] [Abstract][Full Text] [Related]
39. [Effects of rilmenidine on the central nervous system and kidney].
Fillastre JP
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
[TBL] [Abstract][Full Text] [Related]
40. Rilmenidine: a novel approach to first-line treatment of hypertension.
Laurent S; Safar M
Am J Hypertens; 1992 Apr; 5(4 Pt 2):99S-105S. PubMed ID: 1350733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
